Acton, MA, United States of America

Adam G Mcdermott

This inventor holds 2 USPTO granted patents. Top assignee: Nxstage Medical, Inc.. Active years: 2024-2026.


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Adam G Mcdermott

Introduction

Adam G Mcdermott is an accomplished inventor based in Acton, MA (US). He has made significant contributions to the field of optical pressure measurement. His innovative approach has led to the development of a unique pressure measurement system that enhances accuracy and efficiency.

Latest Patents

Adam holds a patent for "Optical pressure measurement devices, methods, and systems." This patent describes a pressure measurement system that includes a pressure pod with two chambers separated by a diaphragm. The deformation or movement of the diaphragm indicates a difference between the pressures of the two chambers. This movement is detected by a device that does not physically contact the diaphragm, such as an optical detector that senses changes in the diaphragm's shape or the movement of a protrusion on the diaphragm.

Career Highlights

Adam is currently employed at Nxstage Medical, Inc., where he continues to innovate in the medical technology sector. His work focuses on developing advanced measurement systems that can improve patient care and medical diagnostics.

Collaborations

Throughout his career, Adam has collaborated with notable colleagues, including Mark T Wyeth and James M Brugger. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Adam G Mcdermott's contributions to optical pressure measurement technology exemplify the spirit of innovation. His work not only advances the field but also has the potential to significantly impact medical practices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…